Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 328

1.

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B.

Genome Res. 2014 Dec;24(12):2022-32. doi: 10.1101/gr.175141.114. Epub 2014 Sep 18.

2.

Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients.

Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW.

Cancer Res. 2013 Jan 1;73(1):30-40. doi: 10.1158/0008-5472.CAN-11-3017. Epub 2012 Nov 7.

3.

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.

Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW.

BMC Cancer. 2012 Feb 28;12:78. doi: 10.1186/1471-2407-12-78.

4.

Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG.

Clin Cancer Res. 2011 Nov 15;17(22):7024-34. doi: 10.1158/1078-0432.CCR-11-1944. Epub 2011 Nov 8.

5.

Response to letter by Pulsipher et al.

Pinkel D.

Leukemia. 2010 Aug;24(8):1532-3. doi: 10.1038/leu.2010.125. Epub 2010 Jun 10. No abstract available.

PMID:
20535154
6.

'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later.

Pinkel D.

Leukemia. 2009 Dec;23(12):2189-96. doi: 10.1038/leu.2009.132. Review. No abstract available.

PMID:
20016481
7.

Quantum dots-based reverse phase protein microarray.

Shingyoji M, Gerion D, Pinkel D, Gray JW, Chen F.

Talanta. 2005 Sep 15;67(3):472-8. doi: 10.1016/j.talanta.2005.06.064. Epub 2005 Aug 10.

PMID:
18970191
8.

High-efficiency microarray printer using fused-silica capillary tube printing pins.

Clark SM, Hamilton GE, Nordmeyer RA, Uber D, Cornell EW, Brown N, Segraves R, Davis R, Albertson DG, Pinkel D.

Anal Chem. 2008 Oct 1;80(19):7639-42. doi: 10.1021/ac8010395. Epub 2008 Sep 3.

PMID:
18763810
9.

Expanding the genetic spectrum of pigmentation.

Bastian BC, Pinkel D.

Pigment Cell Melanoma Res. 2008 Oct;21(5):507-8. doi: 10.1111/j.1755-148X.2008.00490.x. Epub 2007 Aug 20. No abstract available.

PMID:
18721233
10.

Improving melanoma classification by integrating genetic and morphologic features.

Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, Bastian BC.

PLoS Med. 2008 Jun 3;5(6):e120. doi: 10.1371/journal.pmed.0050120.

11.

Comparative genomic hybridization.

DeVries S, Gray JW, Pinkel D, Waldman FM, Sudar D.

Curr Protoc Hum Genet. 2001 May;Chapter 4:Unit4.6. doi: 10.1002/0471142905.hg0406s06.

PMID:
18428281
12.

Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.

North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian BC.

J Invest Dermatol. 2008 Aug;128(8):2024-30. doi: 10.1038/jid.2008.41. Epub 2008 Mar 6.

13.

Roadmap for new opportunities in melanoma research.

Herlyn M, Halaban R, Ronai Z, Schuchter L, Berwick M, Pinkel D.

Semin Oncol. 2007 Dec;34(6):566-76.

PMID:
18083380
14.

Analytical description of mutational effects in competing asexual populations.

Pinkel D.

Genetics. 2007 Dec;177(4):2135-49. Epub 2007 Oct 18.

15.

Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy.

Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R, Pinkel D, Cooper GM, Ventura M, Ropers HH, Tommerup N, Eichler EE, Bellanne-Chantelot C.

Am J Hum Genet. 2007 Nov;81(5):1057-69. Epub 2007 Sep 26.

16.

Absence of PDGFRA mutations in primary melanoma.

Curtin JA, Pinkel D, Bastian BC.

J Invest Dermatol. 2008 Feb;128(2):488-9. Epub 2007 Aug 30. No abstract available.

17.

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.

Oncogene. 2008 Jan 17;27(4):441-9. Epub 2007 Jul 16.

PMID:
17637744
18.

Genome position and gene amplification.

Gajduskova P, Snijders AM, Kwek S, Roydasgupta R, Fridlyand J, Tokuyasu T, Pinkel D, Albertson DG.

Genome Biol. 2007;8(6):R120.

19.

Detection of single clone deletions using array CGH: identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system.

Tokuyasu TA, Cotter PD, Segraves R, Harris J, Elder ME, Gonzales M, Pinkel D, Albertson DG, Rauen KA.

Am J Med Genet A. 2007 May 1;143A(9):925-32.

PMID:
17394204
20.

Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.

Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, Albertson DG, Gray JW, Pinkel D, Lluch A, Martinez-Climent JA.

Cancer Res. 2007 Jan 15;67(2):818-26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk